ArticleClinical rheumatology2023
Development and validation of models for risk of death in patients with systemic lupus erythematosus admitted to the intensive care unit: a retrospective study.
Article in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comprehensive analysis of predictive models for disease manifestations and case fatality in systemic lupus erythematosus.NPJ digital medicine · 2026Review
- Intensive care unit admission and mortality in rheumatic diseases.Rheumatology international · 2025Review
- Prediction of mortality risk in critically ill patients with systemic lupus erythematosus: a machine learning approach using the MIMIC-IV database.Lupus science & medicine · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFor patients with systemic lupus erythematosus (SLE) in the intensive care unit (ICU), early detection of the mortality risk is a significant factor in improving outcomes. In this study, we developed and validated predictive models for the mortality risk.
methodsUsing MIMIC-III v1.4 and MIMIC-IV v0.4, we collected data of patients with SLE who were admitted to the ICU. The patients were divided into two groups based on death or survival within 30 days. Two prediction models were built for each group: a traditional logistic regression model and a linear discriminant analysis (LDA) model constructed by the random subspace method (RSM) (RSM-LDA model). The performance of the two models was analyzed using the area under the receiver operating characteristic curve (AUC).
resultsMIMIC-III and MIMIC-IV were used to establish and validate the models. This study involved 383 patients with SLE, 65 of whom died. They were divided into two groups according to whether they died within 30 days. The predictive factors were the type of admission to the ICU, SLE-associated interstitial pneumonia, lupus nephritis, immunoglobulin G level, and cardiolipin antibody level. A logistic regression model and an RSM-LDA model were established. The AUCs of the two models were 0.87 (95% confidence interval, 0.86-0.90) and 0.91 (95% confidence interval, 0.88-0.93), respectively.
conclusionThe RSM-LDA model can predict the risk of death in patients with SLE admitted to the ICU at an early stage. Key Points • Compared with traditional prediction models, RSM-LDA model has a better ability to predict the risk of death inpatients with systemic lupus erythematosus. • Compared with traditional prediction models, the more input variables (mortality related risk factors), the better the prediction results of RSM-LDA model.
Indexed as
Identifiers
37479889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.